Search results for "Patch tests"
showing 10 items of 22 documents
Kontaktdermatītu raksturojums pacientiem ar psoriāzi
2022
Dermatoloģijas praksē ir svarīgi noskaidrot iespējamos kontaktalergēnus, jo tas ļauj uzlabot pacienta dzīves kvalitāti. Metode, ar kuras palīdzību nosaka kontaktalergēnus, ir vienkārša, pieejama un pacientam nesāpīga. Pacientiem, kuriem ir diagnosticēta psoriāze, ir īpaši ieteicams veikt šādu testu, jo ādas barjerfunkcija ir jau traucēta un tas var palīdzēt izvairīties no lielākiem ādas bojājumiem, kas pasliktinātu dzīves kvalitāti. Par darba mērķis tika izvirzīts, izmantojot aplikācijas testus, noskaidrot biežākos kontaktalergēnus pacientiem ar un bez diagnozes psoriasis vulgaris un vai ir atšķirība starp kontaktalergēniem abās pacientu grupās. Šai nolūkā tika veikts anonimizēts, retrospek…
Chronic Urticaria After Implantation of a Mitral Annuloplasty Ring in a Nickel-Allergic Patient
2017
Patch test results with the metalworking fluid series of the German Contact Dermatitis Research Group (DKG).
2004
Based on the information of the interdisciplinary task force on allergy diagnostics in the metal branch, in 2001, the German Contact Dermatitis Research Group (DKG) compiled two metalworking fluid (MWF) test series with currently and previously used components, respectively. After 2 years of patch testing, we present results obtained with these series, based on data of the Information Network of Departments of Dermatology (IVDK). 251 metalworkers who were patch tested because of suspected MWF dermatitis in 2002 and 2003 were included in this retrospective data analysis. Of these, 206 were tested with the current MWF series and 155 with the historical MWF series. Among the current MWF allerg…
S3 Guidelines: Epicutaneous patch testing with contact allergens and drugs – Short version, Part 2
2019
Epicutaneous patch testing is the diagnostic standard for the detection of allergic contact dermatitis. The present guidelines are aimed at residents and board-certified physicians in the fields of dermatology and allergology as well as other medical specialties involved in establishing the indication for patch testing and its execution in patients with contact dermatitis and other forms of delayed-type hypersensitivity. The target audience also includes other health care providers and insurance funds. Based on a systematic literature search and a formal consensus process (S3), the guidelines were developed by dermatologists in collaboration with pediatricians, occupational medicine physici…
S3 guidelines: Epicutaneous patch testing with contact allergens and drugs – Short version, Part 1
2019
Epicutaneous patch testing is the diagnostic standard for the detection of allergic contact dermatitis. The present guidelines are aimed at residents and board-certified physicians in the fields of dermatology and allergology as well as other medical specialties involved in establishing the indication for patch testing and its execution in patients with contact dermatitis and other forms of delayed-type hypersensitivity. The target audience also includes other health care providers and insurance funds. Based on a systematic literature search and a formal consensus process (S3), the guidelines were developed by dermatologists in collaboration with pediatricians, occupational medicine physici…
Reproducibility of irritant patch test reactions to sodium lauryl sulfate in a double-blind placebo-controlled randomized study using clinical scorin…
1999
Reading of doubtful patch test reactions can be improved by comparing them to defined negative, allergic and irritant controls. For the latter, an irritant patch test is needed that gives sufficiently reproducible results. In our double-blind, placebo-controlled. randomized study, we have analysed the synchronous reproducibility of patch tests with 0%, 0.0625%, 0.125%, 0.25%, 0.5% and 1.0% sodium lauryl sulfate (SLS). Tests and readings were done according to ESCD guidelines. 139 patients (75 women, 64 men) 18 to 77 years old were tested. The % of positive patients as well as the % of reproducible positive reactions increased with rising concentrations of SLS to a maximum of approximately 9…
The spectrum of allergic (cross-)sensitivity in clinical patch testing with 'para amino' compounds
2002
Background: Allergic contact sensitization to ‘para amino’ compounds is frequent and the spectrum of cross-reactivity between members of this chemical group is variable. Methods: A retrospective analysis of clinical patch test data obtained with a special test series in the centres of the Information Network of Departments of Dermatology (IVDK) between 1995 and 1999. Results: In the 638 patients tested with the above test panel positive reactions were observed most often to p-aminoazobenzene (16.2%), p-phenylenediamine (14.1%), p-toluylenediamine (10.0%), followed by 4,4′-diaminodiphenylmethane (8.5%), Disperse Orange 3 (8.4%) and p-aminophenol (3.1%). Among the 544 patients tested with p-p…
Patch testing in children--recommendations of the German Contact Dermatitis Research Group (DKG).
2007
Summary Allergic contact dermatitis occurs frequently in children. Patch testing is needed to identify the responsible allergens and should be performed in children. We recommend a panel of 12 contact allergens as a standard series in children from 6–12 years. Four additional contact allergens should be tested in case of a positive history or suggestive clinical picture. For patch testing in children, the allergens should be applied for 24 hours and the readings should be performed at 48 and 72 hours. Standardized patch testing makes it possible to systematically investigate allergic contact dermatitis and identify relevant allergens in children.
Review of biologics in allergic contact dermatitis
2020
The resistant and recalcitrant nature of severe allergic contact dermatitis (ACD) makes its management challenging. With advances in the understanding of the cellular and molecular pathogenesis of ACD, newer therapeutic targets are becoming apparent. In particular, the use of biologics has gained momentum, given the specificity of their action. This article aims to review the presently available data on the use of biologics in ACD. English-language-based literature available on the use of biological therapy was thoroughly probed in the following databases as on October 14, 2019: PubMed, Google Scholar, The Cochrane library, Embase, Scopus, and EBSCO. The following keywords were used: "conta…